Literature DB >> 2327635

Extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis.

E Blaschke1, A Eklund, R Hernbrand.   

Abstract

In lung sarcoidosis, the mutual relationships of three components of the extracellular matrix, fibronectin (FN), hyaluronan (HA), and type III procollagen peptide (PCP), were investigated in the bronchoalveolar lavage (BAL) fluid. Furthermore, their relation to signs of alveolitis and of fibrosis was examined. Sarcoidosis patients (n = 74) had significantly (p less than 0.001) increased BAL fluid concentrations of FN, HA, and PCP, as well as albumin and lymphocytes, compared to controls (n = 57). The increases were significantly higher in clinically active than in inactive sarcoidosis. FN, HA, and PCP were significantly correlated to markers of alveolitis, such as albumin (r approximately 0.6-0.7; p less than 0.001) and lymphocytes (r approximately 0.4-0.5; p less than 0.001 for FN and HA; p less than 0.05 for PCP), indicating that an alveolar inflammatory process may be a prerequisite for the increased production of the three components. Since correlations between FN and HA and functional parameters (VC, TLC, FEV1.0, and DLCO) were low (r approximately 0.2-0.3, p less than 0.05-0.01 for FN and HA), the increased levels of the extracellular markers do not seem to reflect developed fibrosis. The three markers of extracellular matrix showed significant (p less than 0.001) mutual correlations in the sarcoid patients (r approximately 0.7). FN and HA were correlated even in controls (r = 0.5; p less than 0.01). The findings are in agreement with our hypothesis that these compounds may participate in the buildup of an extracellular network that supports the healing process but in excess may eventually lead to fibrosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327635     DOI: 10.1164/ajrccm/141.4_Pt_1.1020

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Exposure to peat dust: acute effects on lung function and content of bronchoalveolar lavage fluid.

Authors:  T Sandström; B Kolmodin-Hedman; M C Ledin; L Bjermer; S Hörnqvist-Bylund; N Stjernberg
Journal:  Br J Ind Med       Date:  1991-11

Review 2.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Signs of alveolar inflammation in non-smoking Swedish wood trimmers.

Authors:  U Johard; A Eklund; M Dahlqvist; A Ahlander; R Alexandersson; U Ekholm; G Tornling; U Ulfvarsson
Journal:  Br J Ind Med       Date:  1992-06

4.  Long term effects of alumina on components of bronchoalveolar lavage fluid from rats.

Authors:  G Tornling; E Blaschke; A Eklund
Journal:  Br J Ind Med       Date:  1993-02

5.  Immunohistological analysis of sarcoid myopathy.

Authors:  D S Tews; D E Pongratz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

6.  Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Mark J Hamblin; Michael Eberlein; Katharine Black; Robert Hallowell; Samuel Collins; Yee Chan-Li; Maureen R Horton
Journal:  Int J Biomed Sci       Date:  2014-09

Review 7.  The Rise and Fall of Hyaluronan in Respiratory Diseases.

Authors:  Mark E Lauer; Raed A Dweik; Stavros Garantziotis; Mark A Aronica
Journal:  Int J Cell Biol       Date:  2015-09-10

8.  Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients.

Authors:  Carl Hamsten; Emil Wiklundh; Hans Grönlund; Jochen M Schwenk; Mathias Uhlén; Anders Eklund; Peter Nilsson; Johan Grunewald; Anna Häggmark-Månberg
Journal:  Respir Res       Date:  2016-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.